3TC (lamivudine) is now approved for HIV/AIDS in children

January 2001

3TC (lamivudine) is now approved for HIV/AIDS in children.

It had been approved only for patients 12 and older, but now it can be used in kids as young as 3 months. It's also now approved for use with other antiretrovirals besides zidovudine (AZT, Retrovir).

Recommend 4 mg/kg of 3TC twice daily for children...no more than 150 mg/dose.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Cardiology Teveten (eprosartan), a new angiotensin II receptor blocker (ARB)
Cardiology Diovan for heart failure
Gastroenterology new option for bowel cleansing prior to a colonoscopy called Visicol
Iron new injectable forms of iron
3TC (lamivudine) is now approved for HIV/AIDS in children
getting HIV patients to take at least 95% of their antiretroviral meds on time
Enbrel, a new drug for rheumatoid arthritis
IBS treating irritable bowel syndrome
Infectious Diseases Typherix, a new IM vaccine for typhoid fever
Infectious Diseases the trend to write "if-needed" antibiotic Rxs
Some physicians in the U.S. will start getting samples of GENERICS
Supplements using NADH for jet lag
more physicians treat migraines in teenagers with triptans

3TC (lamivudine) is now approved for HIV/AIDS in children

Practical advice for a better career, with unlimited access to CE

Table of Contents